Omada Health, Inc. (OMDA) stock

OMDANasdaqServices-Health ServicesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 13/3056% above fair value

$14.33−0.37 (-2.52%)

Close on Nov 13, 2026Market cap $877.24MP/E –Yield –

Omada Health price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Omada Health's price to sales ratio was 3.0× on Nov 11, 2026, against 4.7× a year earlier.

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	3.0×	−0.9
2025	Dec 31, 2025	3.9×	–

Parsed from the XBRL in Omada Health's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is OMDA.

Revenue growth43.3% · median 14.6%

Gross margin70.7% · median 23.0%

Operating margin2.1% · median 0.3%

Net margin4.2% · median -0.3%

Advertisement
300 × 250

See a number that looks wrong?